US Stock MarketDetailed Quotes

DVA DaVita

Watchlist
  • 133.510
  • +0.740+0.56%
Close Apr 26 16:00 ET
  • 134.450
  • +0.940+0.70%
Post 16:26 ET
11.66BMarket Cap17.99P/E (TTM)

About DaVita Company

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Company Profile

SymbolDVA
Company NameDaVita
Listing DateOct 30, 1995
Issue Price15.50
Founded1994
CEOMr. Javier J. Rodriguez
MarketNYSE
Employees70000
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2000 16th Street
CityDenver
ProvinceColorado
CountryUnited States of America
Zip Code80202-7198
Phone1-720-631-2100

Company Executives

  • Name
  • Position
  • Salary
  • Javier J. Rodriguez
  • Director and Chief Executive Officer
  • 2.98M
  • Joel Ackerman
  • Chief Financial Officer and Treasurer
  • 4.70M
  • Christopher M. Berry
  • Chief Accounting Officer
  • --
  • Kathleen Alyce Waters
  • Chief Legal and Public Affairs Officer
  • 3.53M
  • James O. Hearty
  • Chief Compliance Officer
  • 1.66M
  • Pamela M. Arway
  • Chairman of the Board
  • 469.97K
  • Dennis W. Pullin
  • Director
  • --
  • Barbara J. Desoer
  • Independent Director
  • 367.47K
  • John M. Nehra
  • Independent Director
  • 345.49K
  • Wendy L. Schoppert
  • Independent Director
  • --
  • Adam H. Schechter
  • Independent Director
  • 37.86K
  • Jason M. Hollar
  • Independent Director
  • 144.10K
  • Gregory J Moore
  • Independent Director
  • 294.97K
  • Charles G. Berg
  • Independent Director
  • 284.97K
  • Phyllis R. Yale
  • Independent Director
  • 329.97K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg